ACCESS Newswire

Champions Oncology, Inc.

20.10.2021 16:28:12 CEST | ACCESS Newswire | Press release

Share
Champions Oncology Expands Global Biomarker Capabilities with Opening of European Laboratory at OpenZone Life Sciences Campus

HACKENSACK, NJ / ACCESSWIRE / October 20, 2021 / Champions Oncology (NASDAQ:CSBR), a technology-enabled research organization announced the opening of a European laboratory located in the renowned OpenZone Life Sciences Campus in Bresso, Italy, on the doorstep of Milan.

After launching preclinical and clinical GCLP-compliant biomarker services in 2019, Champions Oncology has rapidly grown to be a leader in the industry by providing scientific expertise, unparalleled quality, and innovative data analytics.

OpenZone is a scientific campus conceived by the healthcare company Zambon to create value in the field of Health, by fostering community, competencies, and capital. With the arrival of Champions Oncology, it is home to 34 enterprises and is undergoing a substantial expansion phase. Thanks to a total investment of around 65 million euros, OpenZone will double in size by 2022, growing to cover a surface area of 37,000 square meters with the capacity to host up to 1,200 people.

To view this piece of content from www.accesswire.com, please give your consent at the top of this page.

"Expanding our laboratory footprint into Europe is a tremendous milestone for Champions," said Ronnie Morris, MD, CEO of Champions Oncology. "Having local/regional access to clinical trial patient samples, some which require less than 24 hours to be processed to achieve accurate readouts, will provide a solution to our clients and also drive growth for our clinical biomarker business in the years to come."

With the unprecedented growth of clinical trials in Europe and the requirement of proximity to access expert biomarker analytical services, Champions is well positioned to serve existing as well as new European clients within the Biotech and Pharmaceutical industries with its expertise in high-dimensional flow cytometry (up to 24-colors) and other analytical techniques as part of Champions' growing portfolio.

About Champions Oncology, Inc.

Champions Oncology is a data-driven research organization, with headquarters in the United States, that leverages an oncology research center of excellence to develop transformative technology and accelerate oncology research and development. This technology ranges from computational-based discovery platforms, unique oncology software solutions, and innovative and proprietary experimental tools such as in vivo, ex-vivo and biomarker platforms. For more information, please visit www.ChampionsOncology.com.

Media Contact:

Rachel Bunting, MS, MBA
Sr. Director, Head of Marketing
Champions Oncology, Inc.
Marketing@championsoncology.com

About OpenZone

OpenZone is the campus, on the doorstep of Milan, dedicated to Health and founded on an approach geared towards open innovation. Conceived by the healthcare company Zambon to build bridges between different languages and worlds, OpenZone mission is to "uniquely create value in Healthcare, by fostering community, competencies and capital". Today the campus is home to 34 enterprises, including some of the foremost biotechnology, pharmaceutical and advanced gene therapy companies, all with a strong penchant for innovation. Work is underway to expand the campus, which, thanks to a total investment of around 65 million euros, will double in size by 2022, growing to cover a surface area of 37,000 square metres, with the capacity to host up to 1,200 people.

OpenZone works closely with all stakeholders in the health sector, to ensure that Milan and Lombardy are increasingly recognized internationally as a territory of excellence for life sciences. Learn more on www.openzone.it/en.

Media Contacts:

Marco Allegrini
Tel: +39 347 339 5615
E: marco.allegrini@zambongroup.com
E: ufficiostampa@openzone.it

Image Building
Cristina Fossati / Angela Fumis
Tel. +39 02 89011300
E: zambon@imagebuilding.it

SOURCE: Champions Oncology, Inc.



View source version on accesswire.com:
https://www.accesswire.com/668789/Champions-Oncology-Expands-Global-Biomarker-Capabilities-with-Opening-of-European-Laboratory-at-OpenZone-Life-Sciences-Campus

To view this piece of content from www.accesswire.com, please give your consent at the top of this page.

About ACCESS Newswire

DK

Subscribe to releases from ACCESS Newswire

Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from ACCESS Newswire

Karbon-X Named Official Sustainability Partner of the Detroit Red Wings and Detroit Tigers1.4.2026 15:00:00 CEST | Press release

Multi-year partnership introduces verified environmental reporting and new fan-driven climate action across Little Caesars Arena and Comerica Park. CALGARY, AB / ACCESS Newswire / April 1, 2026 / Karbon-X Corp. (OTCQX:KARX) ("Karbon-X" or "the Company") today announced a multi-year sustainability partnership with the Detroit Red Wings and Detroit Tigers, establishing Karbon-X as the Official Sustainability Partner across both teams through Ilitch Sports + Entertainment. The collaboration brings verified climate action to two of Detroit's most celebrated franchises, supporting long-term environmental strategy at Little Caesars Arena and Comerica Park, and introducing new ways for fans to participate in meaningful sustainability efforts. As part of the partnership, Karbon-X will deliver independent, third-party greenhouse gas reporting for both organizations. These insights will support future planning and help identify opportunities to strengthen environmental performance across venue o

Datavault AI Returns a Second Time for Exclusive Investor Forum at Mar-a-Lago1.4.2026 14:00:00 CEST | Press release

Private Round Table Follows Tech Summit Appearance in Utah for International Lawyers, Addressing Advancements in AI PHILADELPHIA, PA / ACCESS Newswire / April 1, 2026 / Datavault AI Inc. (NASDAQ:DVLT) CEO Nate Bradley will present at a private investor round table on Thursday, April 02, 2026, at The Mar-a-Lago Club in Palm Beach, Florida, marking his second invitation to the venue in two months following a strong institutional reception in February. The invitation follows presentations Bradley delivered earlier this week to leading global attorneys on AI applications in legal practice and data governance. The return engagement comes amid growing institutional interest in Datavault AI's approach to data monetization, verified credentialing, and real-world asset tokenization. It reflects growing market recognition of Datavault AI's differentiated position at the intersection of data ownership, tokenization, and AI-enabled revenue generation. The April round table builds on momentum from

Jenny Hammarberg Appointed CEO of Lawline - Bringing Legal Expertise to Users Through AI1.4.2026 13:15:00 CEST | Press release

Lawline has appointed Jenny Hammarberg as its new Chief Executive Officer. She joins from her previous role as CEO of Setterwalls Advokatbyrå in Gothenburg and has previous experience as a management consultant at EY. She takes on the role at a pivotal moment as Lawline launches its new platform for businesses, organisations, and private individuals. STOCKHOLM, SE / ACCESS Newswire / April 1, 2026 / Lawline, the market leader for accessible law online since 2005, has set its sights on transforming how legal services are accessed and used. Rather than legal advice being purchased reactively after the fact, the vision is for legal guidance to be available at the moment of decision. "I have seen too many situations where legal counsel arrives when it is already too late - where a simple answer could have saved money, unnecessary frustration, and energy. Legal support should not be something you activate when things are already on fire." - Jenny Hammarberg, CEO, Lawline Lawline is position

Datavault AI and Coppercore Inc. Announce Tokenization of High-Grade Copper Resources into Coppercoin(TM)31.3.2026 15:15:00 CEST | Press release

$100 Million in Initial Coppercoin™ Issuance to Set Industry Standard in Tokenized Copper PHILADELPHIA, PA / ACCESS Newswire / March 31, 2026 / Datavault AI Inc. ("Datavault AI" or the "Company") (NASDAQ:DVLT), a leader in data monetization, credentialing, digital engagement, and real-world asset (RWA) tokenization technologies, and Coppercore Inc. ("Coppercore") today announced the closing of a definitive agreement to digitize and tokenize significant copper resources. The transaction enables Datavault AI to deploy its patented IDE®, DataScore®, and DataValue® blockchain tokenization platform to create Coppercoin™ digital tokens representing pro-rata ownership interests in the underlying in-ground resources. The initial program targets the minting of $100 million or more in Digital Copper Tokens. Coppercoin™ tokens are structured such that each token corresponds to five pounds of underlying high-grade copper resources, with pricing directly linked to the COMEX copper benchmark on a pe

AccessPay Accelerates Growth With Majority Investment From Leading Software Investor, Accel-KKR31.3.2026 10:00:00 CEST | Press release

Financial backing enables AccessPay to scale services for enterprise clients and drive innovation in finance operations MANCHESTER, UK / ACCESS Newswire / March 31, 2026 / AccessPay, a leading bank integration and payment automation provider, has secured a majority investment from Accel-KKR, a prominent global private equity firm specialising in enterprise technology and software companies. The investment is expected to enable AccessPay to fuel the next phase of growth and further its ambition to become a world-class SaaS business driving innovation in the office of the CFO. The investment also opens the door for AccessPay to pursue growth via strategic acquisitions. The office of the CFO faces an increasingly testing operating environment. Alongside cost pressures, increased cyber threats, and a volatile geopolitical climate, AI is fundamentally rewiring finance operating practices. A global McKinsey survey of CFOs from late 2025 reported that 44% of survey respondents had identified

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye